Anti-HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone-Fused Enediyne.

Adv Sci (Weinh) · 2024 · PMC11077693 · PMID 38355309

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

* P < 0.05 was significant difference, ** P < 0.01 and *** P < 0.001 were highly significant difference, ns, no significant difference.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.